Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on left-ventricular mechanical dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging

International Journal of Cardiovascular Imaging

Volumn 28, Issue 6, 2012, Pages 1375-1384

  Chen, Ji ^a   Nagaraj, Hosakote ^b   Bhambhani, Pradeep ^b   Kliner, Dustin E ^c   Soman, Prem ^c   Garcia, Ernest V ^a   Heo, Jaekyeong ^b   Iskandrian, Ami E ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Alcohol septal ablation; Gated SPECT; Hypertrophic cardiomyopathy; LV dyssynchrony; Myocardial perfusion imaging

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ABLATION THERAPY; ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART FAILURE; HEART SEPTUM DEFECT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; LEFT VENTRICULAR MECHANICAL DYSSYNCHRONY; MALE; MYOCARDIAL PERFUSION IMAGING; PHASE ANALYSIS; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SEPTAL ACTIVATION; SEPTAL LATERAL MECHANICAL ACTIVATION DELAY;

ABLATION TECHNIQUES; ADULT; AGED; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84870446226     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-011-9942-y     Document Type: Article

References (32)

1. Wigle ED, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92:1680-1692
2. Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775-785 (Pubitemid 27113973)
3. Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308-1320 (Pubitemid 34250486)
4. Maron MS, Olivotto I, Betocchi S et al (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348:295-303 (Pubitemid 36119984)
5. Maron BJ, Maron MS, Wigle ED, Braunwald E (2009) The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:191-200
6. Autore C, Bernabo P, Barilla CS, Bruzzi P, Spirito P (2005) The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45:1078-1080
7. Elliott PM, Gimeno JR, Tome MT et al (2006) Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27:1933-1941 (Pubitemid 44297366)
8. Ommen SR, Maron BJ, Olivotto I et al (2005) Long term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46:470-476 (Pubitemid 41040288)
9. McLeod CJ, Ommen SR, Ackerman MJ et al (2007) Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 28:2583-2588 (Pubitemid 350071505)
10. Maron MS, Olivotto I, Zenovich AG et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232-2239 (Pubitemid 44789498)
11. Maron BJ (2007) Controversies in cardiovascular medicine. Is septal ablation preferable to surgical myomectomy for obstructive hypertrophic cardiomyopathy? Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 116:196-206
12. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H (2002) Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation 106:454-459 (Pubitemid 34803690)
13. Maron BJ, McKenna WJ, Danielson GK et al (2003) American college of cardiology/European Society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American college of cardiology foundation task force on clinical expert consensus documents and the European society of cardiology committee for practice guidelines. J Am Coll Cardiol 42:1687-1713 (Pubitemid 37383745)
14. Chen J, Garcia EV, Folks RD, Cooke CD, Faber TL, Tauxe EL, Iskandrian AE (2005) Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol 12:687-695 (Pubitemid 43033609)
15. Henneman MM, Chen J, Ypenburg C, Dibbets P, Stokkel M, van der Wall EE, Garcia EV, Bax JJ (2007) Phase analysis of gated myocardial perfusion SPECT compared to tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 49:1708-1714 (Pubitemid 46589921)
16. Marsan NA, Henneman MM, Chen J, Ypenburg C, Dibbets P, Ghio S, Bleeker GB, Stokkel MP, van der Wall EE, Tavazzi L, Garcia EV, Bax JJ (2008) Left ventricular dyssynchrony assessed by two 3-dimensional imaging modalities: phase analysis of gated myocardial perfusion SPECT and tri-plane tissue Doppler imaging. Eur J Nucl Med Mol Imag 35:166-173 (Pubitemid 350234139)
17. Henneman MM, Chen J, Dibbets P, Stokkel M, Bleeker GB, Ypenburg C, van der Wall EE, Schalij MJ, Garcia EV, Bax JJ (2007) Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med 48:1104-1111 (Pubitemid 47052650)
18. Boogers MJ, Chen J, van Bommel RJ, Borleffs CJW, Dibbets-Schneider P, van der Heil B, Younis IA, Schalij MJ, van der Wall EE, Garcia EV, Bax JJ (2011) Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imag 38:230-238
19. Aqel RA, Hage FG, Zohgbi GJ, Tabereaux PB, Lawson D, Heo J, Perry G, Epstein AE, Dell' Italia LJ, Iskandrian AE (2008) Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effect of the changes on clinical status and left ventricular outflow pressure gradients. Am J Cardiol 101:1328-1333
20. Trimble MA, Velazquez EJ, Adams GL, Honeycutt EF, Pagnanelli RA, Barnhart HX, Chen J, Iskandrian AE, Garcia EV, Borges-Neto S (2008) Repeatability and reproducibility of phase analysis of gated SPECT myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl Med Commun 29:374-381 (Pubitemid 351644387)
21. Lin X, Xu H, Zhao X, Folks RD, Faber TL, Garcia EV, Chen J (2010) Repeatability of left ventricular dyssynchrony and function parameters in serial gated myocardial perfusion SPECT studies. J Nucl Cardiol 17:811-816
22. Maron BJ, Olivotto I, Maron MS (2006) The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardio-myopathy: do patients with gradients really deserve prophylactic defibrillators (editorial)? Eur Heart J 27:1895-1897 (Pubitemid 44313587)
23. Slade AKB, Sadoul N, Shapiro L et al (1996) DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. Heart 75:44-49 (Pubitemid 26059968)
24. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D (1994) Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90:2731-2742
25. Kappenberger L, Linde C, Daubert C et al (1997) Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 18:1249-1256 (Pubitemid 27332144)
26. Nishimura RA, Trusty JM, Hayes DL et al (1997) Dualchamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind cross-over study. J Am Coll Cardiol 29:435-441
27. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS (1999) Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind cross-over study (M-PATHY). Circulation 99:2927-2933 (Pubitemid 29258982)
28. Nagakura T, Takeuchi M, Yoshitani H, Nakai H, Nishikage T, Kokumai M, Otani S, Yoshiyama M, Yoshikawa J (2007) Hypertrophic cardiomyopathy is associated with more severe left ventricular dyssynchrony than is hypertensive left ventricular hypertrophy. Echocardiography 24:677-684 (Pubitemid 47094227)
29. D'Andrea A, Caso P, Severino S, Scotto di Uccio F, Vigorito F, Ascione L, Scherillo M, Calabro R (2005) Association between intraventricular myocardial systolic dyssynchrony and ventricular arrhythmias in patients with hypertrophic cardiomyopathy. Echocardiography 22:571-578 (Pubitemid 41603163)
30. Bax JJ, Bleeker GB, Marwick TH et al (2004) Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44:1834-1840 (Pubitemid 39424084)
31. Bax JJ, Marwick TH, Molhoek SG et al (2003) Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 92:1238-1240 (Pubitemid 37377846)
32. Chung ES, Leon AR, Tavazzi L et al (2008) Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117:2608-2616